相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Artificially Induced Protein-Membrane Anchorage with Cholesterol-Based Recognition Agents as a New Therapeutic Concept
Miriam Avadisian et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Design, synthesis and in vitro characterization of novel hybrid peptidomimetic inhibitors of STAT3 protein
Vijay M. Shahani et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Small-Molecule Inhibitors of the ERK Signaling Pathway: Towards Novel Anticancer Therapeutics
Jeremy L. Yap et al.
CHEMMEDCHEM (2011)
Antagonism of the Stat3-Stat3 Protein Dimer with Salicylic Acid Based Small Molecules
Steven Fletcher et al.
CHEMMEDCHEM (2011)
Potent and Selective Phosphopeptide Mimetic Prodrugs Targeted to the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 3
Pijus K. Mandal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Identification of Purine-Scaffold Small-Molecule Inhibitors of Stat3 Activation by QSAR Studies
Vijay M. Shahini et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1α inhibitors
Kazuki Shimizu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Coordination complex SH2 domain proteomimetics: an alternative approach to disrupting oncogenic protein-protein interactions
Joel A. Drewry et al.
CHEMICAL COMMUNICATIONS (2010)
Small-Molecule Inhibitors of the Hedgehog Signaling Pathway as Cancer Therapeutics
Stefan Peukert et al.
CHEMMEDCHEM (2010)
Identification of HSP60 as a Primary Target of o-Carboranylphenoxyacetanilide, an HIF-1α Inhibitor
Hyun Seung Ban et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Concise access to N9-mono-, N2-mono- and N2,N9-di-substituted guanines via efficient Mitsunobu reactions
Steven Fletcher et al.
TETRAHEDRON (2010)
Structure-Based Design of Conformationally Constrained, Cell-Permeable STAT3 Inhibitors
Jianyong Chen et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Analysis of HIF-1 inhibition by manassantin A and analogues with modified tetrahydrofuran configurations
Amanda C. Kasper et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Small molecule inhibitors of Myc/Max dimerization and Myc-induced cell transformation
Jin Shi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Disruption of Transcriptionally Active Stat3 Dimers with Non-phosphorylated, Salicylic Acid-Based Small Molecules: Potent in vitro and Tumor Cell Activities
Steven Fletcher et al.
CHEMBIOCHEM (2009)
Structure-Affinity Relationships of Glutamine Mimics Incorporated into Phosphopeptides Targeted to the SH2 Domain of Signal Transducer and Activator of Transcription 3
Pijus K. Mandal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Conformationally Constrained Peptidomimetic Inhibitors of Signal Transducer and Activator of Transcription 3: Evaluation and Molecular Modeling
Pijus K. Mandal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Discovery of Inhibitors of Aberrant Gene Transcription from Libraries of DNA Binding Molecules: Inhibition of LEF-1-Mediated Gene Transcription and Oncogenic Transformation
James S. Stover et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Multiple Independent Binding Sites for Small-Molecule Inhibitors on the Oncoprotein c-Myc
Dalia I. Hammoudeh et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Synthesis of Phosphatase-Stable, Cell-Permeable Peptidomimetic Prodrugs That Target the SH2 Domain of Stat3
Pijus K. Mandal et al.
ORGANIC LETTERS (2009)
Nucleophilic Addition of Organozinc Reagents to 2-Sulfonyl Cyclic Ethers: Stereoselective Synthesis of Manassantins A and B
Hyoungsu Kim et al.
ORGANIC LETTERS (2009)
Allosteric modulation of DNA by small molecules
David M. Chenoweth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Facile and efficient access to 2,6,9-tri-substituted purines through sequential N9, N2 Mitsunobu reactions
Steven Fletcher et al.
TETRAHEDRON LETTERS (2009)
Structural Rationale for the Coupled Binding and Unfolding of the c-Myc Oncoprotein by Small Molecules
Ariele Viacava Follis et al.
CHEMISTRY & BIOLOGY (2008)
Molecular approaches towards the inhibition of the signal transducer and activator of transcription 3 (Stat3) protein
Steven Fletcher et al.
CHEMMEDCHEM (2008)
Inhibition of transcription factors with small organic molecules
Thorsten Berg
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1
Yukihiko Aikawa et al.
NATURE BIOTECHNOLOGY (2008)
Improved low molecular weight Myc-Max inhibitors
Huabo Wang et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Design and synthesis of a new, conformationally constrained, macrocyclic small-molecule inhibitor of STAT3 via 'click chemistry'
Jianyong Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity
Khandaker Siddiquee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Selective inhibition of c-Myc/Max dimerization by a pyrazolo[1,5-a]-pyrimidine
Anke Kiessling et al.
CHEMMEDCHEM (2007)
The Myc oncoprotein as a therapeutic target for human cancer
Marina Vita et al.
SEMINARS IN CANCER BIOLOGY (2006)
Mechanism of transcriptional activation by the Myc oncoproteins
Victoria H. Cowling et al.
SEMINARS IN CANCER BIOLOGY (2006)
Programmable oligomers for minor groove DNA recognition
Raymond M. Doss et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules
Anke Kiessling et al.
CHEMISTRY & BIOLOGY (2006)
Identification of small molecules that induce apoptosis in a Myc-dependent manner and inhibit Myc-driven transformation
H Mo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A credit-card library approach for disrupting protein-protein interactions
Y Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome
M Groll et al.
STRUCTURE (2006)
Discovery of nonpeptidic small-molecule AP-1 inhibitors: Lead hopping based on a three-dimensional pharmacophore model
K Tsuchida et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Small molecule modulators of transcription
Hans-Dieter Arndt
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
Protein surface recognition and proteomimetics: mimics of protein surface structure and function
S Fletcher et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2005)
Cancer therapeutics: Targeting the dark side of Myc
R Ponzielli et al.
EUROPEAN JOURNAL OF CANCER (2005)
Investigation of the binding determinants of phosphopeptides targeted to the Src homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor
DR Coleman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Chemical approaches to transcriptional regulation
CY Majmudar et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2005)
Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity
DH Kong et al.
CANCER RESEARCH (2005)
Transcriptional regulation and transformation by MYC proteins
S Adhikary et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Regulation of the versican promoter by the β-catenin-T-cell factor complex in vascular smooth muscle cells
M Rahmani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Molecular-targeted antitumor agents:: The Saururus cernuus dineolignans manassantin B and 4-O-demethylmanassantin B are potent inhibitors of hypoxia-activated HIF-1
TW Hodges et al.
JOURNAL OF NATURAL PRODUCTS (2004)
Design, synthesis, and biological evaluation of new cyclic disulfide decapeptides that inhibit the binding of AP-1 to DNA
K Tsuchida et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
AP-1 subunits: quarrel and harmony among siblings
J Hess et al.
JOURNAL OF CELL SCIENCE (2004)
Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
BZ Olenyuk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
HIF-1 as a target for drug development
A Giaccia et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Low molecular weight inhibitors of Myc-Max interaction and function
XY Yin et al.
ONCOGENE (2003)
X-ray structures of Myc-Max and Mad-Max recognizing DNA: Molecular bases of regulation by proto-oncogenic transcription factors
SK Nair et al.
CELL (2003)
New and known symmetrical curcumin derivatives inhibit the formation of Fos-Jun-DNA complex
ER Hahm et al.
CANCER LETTERS (2002)
c-MYC: More than just a matter of life and death
S Pelengaris et al.
NATURE REVIEWS CANCER (2002)
AP-1 as a regulator of cell life and death
E Shaulian et al.
NATURE CELL BIOLOGY (2002)
Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts
T Berg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A conserved family of prolyl-4-hydroxylases that modify HIF
RK Bruick et al.
SCIENCE (2001)
Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc
W Fieber et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Momordin I, a compound of ampelopsis radix, inhibits AP-1 activation induced by phorbol ester
S Park et al.
CANCER LETTERS (2000)
分享论文
